Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

UPDATES

$Immuneering (IMRX.US)$ Immuneering To Present Phase 2a Trial Data For IMM-1-104 In First-Line And Second-Line Pancreatic Cancer, Along With Phase 1 Data For IMM-6-415, At Virtual Investor Event In January 2025
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
Translate
Report
224 Views
Comment
Sign in to post a comment